ArticleScientific reports2022

LRP-1 receptor combines EGFR signalling and eHsp90α autocrine to support constitutive breast cancer cell motility in absence of blood supply.

Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.